Related Experiment Video

Updated: Jul 11, 2026

Pulse-Wave Velocity, Flow-Mediated Dilation, and Carotid Intima-Media Thickness to Assess Cardiovascular Risk in Population with Metabolic Syndrome
06:04

Pulse-Wave Velocity, Flow-Mediated Dilation, and Carotid Intima-Media Thickness to Assess Cardiovascular Risk in Population with Metabolic Syndrome

Published on: September 27, 2024

[Frequency of cardiovascular risk factors and co-morbidity in patients with rheumatic diseases]

Philippe Bertin1

  • 1CHU Dupuytren, Service de Thérapeutique et de Rhumatologie, Limoges.

Presse Medicale (Paris, France : 1983)
|December 6, 2007
PubMed

Insights

Patients with rheumatic diseases face higher cardiovascular risks, especially when using non-steroidal anti-inflammatory drugs long-term. Understanding these risks aids rheumatologists in better patient management.

Area of Science:

  • Rheumatology and Cardiovascular Health
  • Public Health and Epidemiology

Context:

  • National data (2002-2005) reveal high cardiovascular disease and risk factor prevalence in the general population.
  • Rheumatology practice is significantly impacted by cardiovascular comorbidities.
  • Patients with rheumatoid arthritis and spondylarthropathy exhibit increased cardiovascular pathology frequency.

Purpose:

  • To analyze cardiovascular risks within the context of rheumatology practice.
  • To highlight the importance of cardiovascular risk factors in patients with rheumatic diseases.
  • To inform therapeutic decision-making regarding non-steroidal anti-inflammatory drug (NSAID) use in rheumatology.

Summary:

  • Analysis of national health data indicates a high burden of cardiovascular disease and risk factors.
  • Rheumatic conditions like rheumatoid arthritis and spondylarthropathy are associated with elevated cardiovascular risks.
  • Long-term NSAID use in these patient populations necessitates careful benefit/risk assessment.

Impact:

  • Provides crucial knowledge for rheumatologists to estimate individual benefit/risk ratios for prescriptions.
  • Enhances therapeutic strategies by integrating cardiovascular risk assessment.
  • Specifically guides the judicious use of non-steroidal anti-inflammatory drugs in patients with rheumatic diseases.

Related Concept Videos

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
Rheumatic Heart Disease IV: Nursing Management01:20

Rheumatic Heart Disease IV: Nursing Management

AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...